Hla A2 Negative Metastatic Uveal Melanoma clinical trials

Explore recruiting hla a2 negative metastatic uveal melanoma clinical trials.

Also recruiting in Europe

Hla A2 Negative Metastatic Uveal Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IDE196 (Darovasertib) in Combination with Crizotinib Versus Investigator’s Choice of Treatment as First-line Therapy in HLA-A2 Negative Metastatic Uveal Melanoma

Spain, Italy, Poland, Germany, Belgium, France +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

IDE196 (Darovasertib) in Combination with Crizotinib Versus Investigator’s Choice of Treatment as First-line Therapy in HLA-A2 Negative Metastatic Uveal Melanoma

Belgium

Phase II and Phase III (Integrated) EU CTIS Study details

Hla A2 Negative Metastatic Uveal Melanoma trials by city

Hla A2 Negative Metastatic Uveal Melanoma in Toronto Hla A2 Negative Metastatic Uveal Melanoma in Vancouver Hla A2 Negative Metastatic Uveal Melanoma in Montreal Hla A2 Negative Metastatic Uveal Melanoma in Calgary Hla A2 Negative Metastatic Uveal Melanoma in Edmonton Hla A2 Negative Metastatic Uveal Melanoma in Ottawa Hla A2 Negative Metastatic Uveal Melanoma in Winnipeg Hla A2 Negative Metastatic Uveal Melanoma in Quebec City Hla A2 Negative Metastatic Uveal Melanoma in Hamilton Hla A2 Negative Metastatic Uveal Melanoma in Kitchener Hla A2 Negative Metastatic Uveal Melanoma in London Hla A2 Negative Metastatic Uveal Melanoma in Halifax Hla A2 Negative Metastatic Uveal Melanoma in New York Hla A2 Negative Metastatic Uveal Melanoma in Los Angeles Hla A2 Negative Metastatic Uveal Melanoma in Chicago Hla A2 Negative Metastatic Uveal Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease